These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28387249)
1. Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells. Chao MW; Chen TH; Huang HL; Chang YW; HuangFu WC; Lee YC; Teng CM; Pan SL Sci Rep; 2017 Apr; 7():46134. PubMed ID: 28387249 [TBL] [Abstract][Full Text] [Related]
2. Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status. Durmaz I; Guven EB; Ersahin T; Ozturk M; Calis I; Cetin-Atalay R Phytomedicine; 2016 Jan; 23(1):42-51. PubMed ID: 26902406 [TBL] [Abstract][Full Text] [Related]
3. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis. Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542 [TBL] [Abstract][Full Text] [Related]
4. Cardiac glycoside sensitized hepatocellular carcinoma cells to TRAIL via ROS generation, p38MAPK, mitochondrial transition, and autophagy mediation. Rasheduzzaman M; Yin H; Park SY Mol Carcinog; 2019 Nov; 58(11):2040-2051. PubMed ID: 31392779 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition by pennogenyl saponins from Rhizoma paridis on hepatoma xenografts in nude mice. Chen YS; He Y; Chen C; Zeng Y; Xue D; Wen FY; Wang L; Zhang H; Du JR Steroids; 2014 May; 83():39-44. PubMed ID: 24530287 [TBL] [Abstract][Full Text] [Related]
6. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo. Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661 [TBL] [Abstract][Full Text] [Related]
7. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways. Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344 [TBL] [Abstract][Full Text] [Related]
8. Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell. Hu Y; Yu K; Wang G; Zhang D; Shi C; Ding Y; Hong D; Zhang D; He H; Sun L; Zheng JN; Sun S; Qian F Biochem Pharmacol; 2018 Apr; 150():280-292. PubMed ID: 29475060 [TBL] [Abstract][Full Text] [Related]
9. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells. Kim YW; Jang EJ; Kim CH; Lee JH Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897 [TBL] [Abstract][Full Text] [Related]
10. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227 [TBL] [Abstract][Full Text] [Related]
11. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
12. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo. Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959 [TBL] [Abstract][Full Text] [Related]
13. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway. Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446 [TBL] [Abstract][Full Text] [Related]
14. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497 [TBL] [Abstract][Full Text] [Related]
15. PKI 166 induced redox signalling and apoptosis through activation of p53, MAP kinase and caspase pathway in epidermoid carcinoma. Das S; Dey KK; Bharti R; MaitiChoudhury S; Maiti S; Mandal M J Exp Ther Oncol; 2012; 10(2):139-53. PubMed ID: 23350354 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Yang J; Pi C; Wang G Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738 [TBL] [Abstract][Full Text] [Related]
17. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740 [TBL] [Abstract][Full Text] [Related]
18. Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. Yoon CH; Kim MJ; Park MJ; Park IC; Hwang SG; An S; Choi YH; Yoon G; Lee SJ J Biol Chem; 2010 Jan; 285(1):226-33. PubMed ID: 19897486 [TBL] [Abstract][Full Text] [Related]
19. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Kuo PL; Chen CY; Hsu YL Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma. Liu Y; Sun L; Su X; Guo S Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]